CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-07
DOI
10.1038/s41467-018-03031-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ARID1A-mutated ovarian cancers depend on HDAC6 activity
- (2017) Benjamin G. Bitler et al. NATURE CELL BIOLOGY
- Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target
- (2016) Alfredo Perales-Puchalt et al. CLINICAL CANCER RESEARCH
- Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening
- (2016) Renato Ferreira de Freitas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer
- (2016) Yi-Ping Wang et al. MOLECULAR CELL
- Dynamics of BAF–Polycomb complex opposition on heterochromatin in normal and oncogenic states
- (2016) Cigall Kadoch et al. NATURE GENETICS
- SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
- (2015) Kimberly H Kim et al. NATURE MEDICINE
- Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. NATURE MEDICINE
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
- (2015) C. Kadoch et al. Science Advances
- CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis
- (2014) Lu Wang et al. CANCER CELL
- 6LBA Phase 1 first-in-human study of the enhancer of zeste-homolog 2 (EZH2) histone methyl transferase inhibitor E7438 as a single agent in patients with advanced solid tumors or B cell lymphoma
- (2014) V. Ribrag et al. EUROPEAN JOURNAL OF CANCER
- An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
- (2013) Kyle D. Konze et al. ACS Chemical Biology
- Coming into focus: the nonovarian origins of ovarian cancer
- (2013) L. Dubeau et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- GAP-independent functions of DLC1 in metastasis
- (2013) David Barras et al. CANCER AND METASTASIS REVIEWS
- PELP1 oncogenic functions involve CARM1 regulation
- (2013) M. Mann et al. CARCINOGENESIS
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
- (2013) Katherine M. Aird et al. Cell Reports
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
- (2011) B. G. Bitler et al. CANCER RESEARCH
- Oncogenic Ras Regulates BRIP1 Expression to Induce Dissociation of BRCA1 from Chromatin, Inhibit DNA Repair, and Promote Senescence
- (2011) Zhigang Tu et al. DEVELOPMENTAL CELL
- Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity
- (2011) Donghang Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- Enhancer of Zeste Homolog 2 Promotes the Proliferation and Invasion of Epithelial Ovarian Cancer Cells
- (2010) H. Li et al. MOLECULAR CANCER RESEARCH
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
- (2010) Sven Heinz et al. MOLECULAR CELL
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
- (2009) Samuel C. Mok et al. CANCER CELL
- Enzymatic Activity Is Required for thein VivoFunctions of CARM1
- (2009) Daehoon Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Noxa: at the tip of the balance between life and death
- (2009) C Ploner et al. ONCOGENE
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from BRCA Mutation Carriers Resemble High-Grade Serous Carcinoma
- (2008) A. A. Tone et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More